Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA.
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.
Nicotine Tob Res. 2020 Jun 12;22(7):1170-1177. doi: 10.1093/ntr/ntz168.
Smoking is a key determinant of mortality among people living with HIV (PLWH).
To better understand the effects of smoking cessation interventions in PLWH, we conducted a pooled analysis of four randomized controlled trials of hospital-initiated smoking interventions conducted through the Consortium of Hospitals Advancing Research on Tobacco (CHART). In each study, cigarette smokers were randomly assigned to usual care or a smoking cessation intervention. The primary outcome was self-reported past 30-day tobacco abstinence at 6-month follow-up. Abstinence rates were compared between PLWH and participants without HIV and by treatment arm, using both complete-case and intention-to-treat analyses. Multivariable logistic regression was used to determine the effect of HIV status on 6-month tobacco abstinence and to determine predictors of smoking cessation within PLWH.
Among 5550 hospitalized smokers, there were 202 (3.6%) PLWH. PLWH smoked fewer cigarettes per day and were less likely to be planning to quit than smokers without HIV. At 6 months, cessation rates did not differ between intervention and control groups among PLWH (28.9% vs. 30.5%) or smokers without HIV (36.1% vs. 34.1%). In multivariable regression analysis, HIV status was not significantly associated with smoking cessation at 6 months. Among PLWH, confidence in quitting was the only clinical factor independently associated with smoking cessation (OR 2.0, 95% CI = 1.4 to 2.8, p < .01).
HIV status did not alter likelihood of quitting smoking after hospital discharge, whether or not the smoker was offered a tobacco cessation intervention, but power was limited to identify potentially important differences.
PLWH had similar quit rates to participants without HIV following a hospital-initiated smoking cessation intervention. The findings suggest that factors specific to HIV infection may not influence response to smoking cessation interventions and that all PLWH would benefit from efforts to assist in quitting smoking.
(1) Using "warm handoffs" to link hospitalized smokers with tobacco treatment after discharge: study protocol of a randomized controlled trial: NCT01305928. (2) Web-based smoking cessation intervention that transitions from inpatient to outpatient: NCT01277250. (3) Effectiveness of smoking-cessation interventions for urban hospital patients: NCT01363245. (4) Effectiveness of Post-Discharge Strategies for Hospitalized Smokers (HelpingHAND2): NCT01714323.
吸烟是影响 HIV 感染者(PLWH)死亡率的关键因素。
为了更好地了解戒烟干预措施对 PLWH 的影响,我们对通过 Consortium of Hospitals Advancing Research on Tobacco(CHART)开展的 4 项医院发起的戒烟干预随机对照试验进行了汇总分析。在每项研究中,将吸烟者随机分配至常规护理或戒烟干预组。主要结局是在 6 个月随访时自我报告的过去 30 天内烟草戒断情况。使用完全案例和意向治疗分析,比较 PLWH 与无 HIV 参与者以及不同治疗组之间的戒断率。多变量逻辑回归用于确定 HIV 状态对 6 个月烟草戒断的影响,并确定 PLWH 中戒烟的预测因素。
在 5550 名住院吸烟者中,有 202 名(3.6%)PLWH。与无 HIV 的吸烟者相比,PLWH 每天吸烟较少,且计划戒烟的可能性较小。在 6 个月时,干预组和对照组之间的戒烟率在 PLWH 中没有差异(28.9%比 30.5%)或无 HIV 的吸烟者中也没有差异(36.1%比 34.1%)。在多变量回归分析中,HIV 状态与 6 个月时的戒烟情况没有显著关联。在 PLWH 中,戒烟信心是唯一与戒烟独立相关的临床因素(OR 2.0,95%CI=1.4 至 2.8,p<0.01)。
无论吸烟者是否接受了戒烟干预,HIV 状态都不会改变出院后戒烟的可能性,但该研究的效力有限,无法确定可能存在的重要差异。
PLWH 在接受医院发起的戒烟干预后,其戒烟率与无 HIV 的参与者相似。这些发现表明,HIV 感染的特定因素可能不会影响对戒烟干预的反应,所有 PLWH 都将受益于帮助其戒烟的努力。
(1)使用“热交接”将住院吸烟者与出院后的烟草治疗联系起来:一项随机对照试验的研究方案:NCT01305928。(2)基于网络的戒烟干预措施,从住院过渡到门诊:NCT01277250。(3)城市医院患者戒烟干预措施的有效性:NCT01363245。(4)住院吸烟者出院后策略的有效性(HelpingHAND2):NCT01714323。